A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose
- 1 November 1999
- journal article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 44 (5) , 701-704
- https://doi.org/10.1093/jac/44.5.701
Abstract
A single 400 mg oral dose of gatifloxacin was given to each of nine healthy male volunteers and the concentrations of the drug in plasma, cantharidine-induced inflammatory fluid and urine were measured over the following 24 h. The mean peak concentration in plasma of 4. 1 mg/L was attained at a mean time of 1.8 h post dose. The mean peak concentration in inflammatory fluid was 3.6 mg/L and was attained at a mean time of 4.2 h post dose. The mean plasma elimination half-life of gatifloxacin was 6.8 h and that in inflammatory fluid was 7.2 h. The mean penetration into the inflammatory fluid was 117%. Recovery of drug from urine during the first 24 h post dose was 65% of that administered. Our data suggest that gatifloxacin dosed at 400 mg od should be adequate to treat systemic infections caused by most bacterial species.Keywords
This publication has 4 references indexed in Scilit:
- The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.Journal of Antimicrobial Chemotherapy, 1997
- Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humansAntimicrobial Agents and Chemotherapy, 1995
- Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacinAntimicrobial Agents and Chemotherapy, 1995
- In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinoloneAntimicrobial Agents and Chemotherapy, 1994